TALK vs. INNV, WGS, PNTG, DCGO, SHCR, PIII, VALN, IRMD, OABI, and ANL
Should you be buying Talkspace stock or one of its competitors? The main competitors of Talkspace include InnovAge (INNV), GeneDx (WGS), The Pennant Group (PNTG), DocGo (DCGO), Sharecare (SHCR), P3 Health Partners (PIII), Valneva (VALN), Iradimed (IRMD), OmniAb (OABI), and Adlai Nortye (ANL). These companies are all part of the "medical" sector.
Talkspace (NASDAQ:TALK) and InnovAge (NASDAQ:INNV) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, media sentiment, risk, community ranking, dividends, profitability, analyst recommendations, institutional ownership and valuation.
Talkspace has a beta of 1.29, meaning that its share price is 29% more volatile than the S&P 500. Comparatively, InnovAge has a beta of 0.24, meaning that its share price is 76% less volatile than the S&P 500.
57.4% of Talkspace shares are owned by institutional investors. Comparatively, 12.3% of InnovAge shares are owned by institutional investors. 18.4% of Talkspace shares are owned by company insiders. Comparatively, 0.4% of InnovAge shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
Talkspace has higher earnings, but lower revenue than InnovAge. Talkspace is trading at a lower price-to-earnings ratio than InnovAge, indicating that it is currently the more affordable of the two stocks.
In the previous week, InnovAge had 3 more articles in the media than Talkspace. MarketBeat recorded 6 mentions for InnovAge and 3 mentions for Talkspace. InnovAge's average media sentiment score of 0.24 beat Talkspace's score of 0.12 indicating that InnovAge is being referred to more favorably in the news media.
Talkspace presently has a consensus price target of $3.00, suggesting a potential downside of 5.66%. InnovAge has a consensus price target of $6.50, suggesting a potential upside of 50.46%. Given InnovAge's higher possible upside, analysts clearly believe InnovAge is more favorable than Talkspace.
InnovAge has a net margin of -4.38% compared to Talkspace's net margin of -12.78%. InnovAge's return on equity of -10.53% beat Talkspace's return on equity.
Talkspace and InnovAge both received 0 outperform votes by MarketBeat users.
Summary
InnovAge beats Talkspace on 8 of the 14 factors compared between the two stocks.
Get Talkspace News Delivered to You Automatically
Sign up to receive the latest news and ratings for TALK and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding TALK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Talkspace Competitors List
Related Companies and Tools
